The CIBER-BBN project \u2018Desarrollo de Nanomedicinas para terapia enzim\u00e1tica sustitutiva en la enfermedad de Fabry\u2019 is one of\u00a0 20 biomedical projects to receive a slice of more than \u20ac7m from the foundation, which aims to foster and promote research into rare diseases, in part with its annual telethon \u2018La Marat\u00f3 de TV3\u2019. The project aims to obtain a new therapeutic nanoconjugate for substitutive enzymatic therapy in patients with Fabry disease, a hard-to-diagnose illness caused by the deficiency of an enzyme needed to metabolize lipids, which then build to harmful levels in the eyes, kidneys, and cardiovascular and nervous systems.<\/p>\n
The IBEC groups of Fausto Sanz and Mar\u00eda Garc\u00eda-Parajo are involved in the project, which will run for another three years. The funding is awarded on a merit basis, and the total received by the Fabry project is one of the largest portions of the \u20ac7,120,569 total.<\/p>\n